Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | N/A | N/A | N/A | 1,463,800 | 1,277,300 |
| Accounts receivable | -119,100 | -24,500 | -135,500 | -9,200 | -940,100 |
| Other Working Capital | -113,800 | 72,900 | -185,300 | -123,700 | -1,023,600 |
| Other Operating Activity | 803,800 | 704,000 | 742,500 | 7,749,000 | 8,373,700 |
| Operating Cash Flow | $570,900 | $752,400 | $421,700 | $9,079,900 | $7,687,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1,431,100 | -239,600 | 84,500 | -2,724,700 | -2,727,800 |
| Purchase Of Investment | -98,700 | -45,200 | -29,900 | -34,780,400 | -28,637,100 |
| Sale Of Investment | N/A | N/A | N/A | 33,383,000 | 27,667,500 |
| Purchase Sale Intangibles | -20,800 | -25,600 | -34,800 | N/A | N/A |
| Other Investing Activity | 0 | 0 | 0 | -190,200 | 56,100 |
| Investing Cash Flow | $1,311,600 | $-310,400 | $19,800 | $-4,312,300 | $-3,641,300 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,616,900 | -469,700 | -286,300 | N/A | N/A |
| Common Stock Issued | 38,200 | 404,200 | 0 | 300,600 | 2,140,700 |
| Common Stock Repurchased | N/A | N/A | N/A | -3,890,800 | -3,545,400 |
| Dividend Paid | -44,200 | -53,900 | -49,500 | -3,145,000 | -2,798,000 |
| Other Financing Activity | -95,900 | -341,200 | 852,900 | 1,664,000 | 755,300 |
| Financing Cash Flow | $-1,718,800 | $-460,600 | $517,100 | $-5,071,200 | $-3,447,400 |
| Exchange Rate Effect | -6,600 | -23,100 | -49,500 | -89,200 | -83,700 |
| Beginning Cash Position | 297,800 | 339,400 | 464,200 | 2,536,800 | 2,021,900 |
| End Cash Position | 369,700 | 297,800 | 339,400 | 2,144,000 | 2,536,800 |
| Net Cash Flow | $163,700 | $-18,600 | $958,600 | $-303,600 | $598,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 570,900 | 752,400 | 421,700 | 9,079,900 | 7,687,300 |
| Capital Expenditure | -255,100 | -306,400 | -411,800 | -2,724,700 | -2,727,800 |
| Free Cash Flow | 315,800 | 446,000 | 9,900 | 6,355,200 | 4,959,500 |